基于FAERS数据库的基础上,挖掘和分析与佩拉曼奈尔相关的不良药物反应
Pengcheng Liu1, Yuwei Zhang1, Xiaoli Xu1
1China Pharmaceutical University School of International Pharmaceutical Business, Nanjing 211198, China.
Epilepsy & behavior : E&B
|June 14, 2023
概括
佩拉曼奈尔 (PER) 是一种抗发作药物,可能会导致严重的副作用,包括自杀行为,呼吸系统抑郁,肝毒性和认知障碍. 在PER治疗期间,密切监测心理健康和行为变化至关重要.
科学领域:
- 药物监督 药物监督 药物监督
- 神经科学是一个神经科学.
- 临床药理学 临床药理学
背景情况:
- 对于像Perampanel (PER) 这样的新型抗发作药物的大量营销后安全数据是有限的.
- 了解PER的安全性概况对于明智的临床决策至关重要.
研究的目的:
- 使用大型不良事件数据库调查和评估Perampanel (PER) 的安全性.
- 为了识别与PER使用相关的潜在不良反应信号.
主要方法:
- 使用了FDA的不良事件报告系统 (FAERS) 数据库.
- 采用信号挖掘技术,包括报告几率比率 (ROR),MHRA和贝叶斯信任传播神经网络 (BCPNN).
主要成果:
- 检测到83个对Perampanel (PER) 的不良反应信号,主要与精神病和神经系统疾病有关.
- 确定了包括自杀行为,呼吸系统抑郁,肝毒性和认知障碍在内的显著信号.
- 在老年,男性和女性患者中观察到特定风险,需要量身定制的监测.
结论:
- 佩拉曼内尔 (PER) 与自杀行为,呼吸系统抑郁,肝毒性和认知障碍的风险有关.
- 临床使用PER需要对不良心理健康和行为影响进行警监测.
- 由于数据源的性质,研究结果应谨慎解释.
更多相关视频
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
9.7K
10:41Laser-Induced Action Potential-Like Measurements of Cardiomyocytes on Microelectrode Arrays for Increased Predictivity of Safety Pharmacology
Published on: September 13, 2022
2.1K
相关概念视频
Pharmacovigilance
914
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
914
Antiepileptic Drugs: Glutamate Antagonists
435
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
435
Antiepileptic Drugs: Potassium Channel Activators
218
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
218
